Public ID: PID-GR8DY9

Ineffective health technology assessment (HTA) procedures for innovative medicines in Ecuador

in Ecuador

Trade barrier summary

Ecuador's HTA processes lack coordination and predictability due to decentralised management of these. This harms UK pharmaceutical exports by undermining the adoption of innovative and cost-effective UK drugs in the Ecuadorean health system.


Sectors affected

  • Pharmaceuticals and biotechnology
  • Medical devices and equipment
  • Healthcare services

Resolved

No


Date reported

4 January 2023


Last updated

6 January 2026


Public ID

PID-GR8DY9


Back to search results

If a trade barrier is affecting your exports or investment from the UK, please let us know on report a trade barrier .

If you export goods you can check duties and customs procedures for your chosen market.